Endocrine-Disrupting Potential of Rayon
Rayon (including viscose/rayon fibers) has not been demonstrated in the peer-reviewed endocrine-disruption literature to act as an endocrine-disrupting chemical (EDC) on the basis of its chemical identity as a fiber product. An EDC is defined as an exogenous chemical or mixture that interferes with hormone action. [1]
Evidence Standard for Endocrine Disruption
Endocrine disruption determination typically requires evidence across relevant endocrine endpoints in laboratory models and supportive mechanistic or observational evidence. [2]
Rayon Versus Rayon-Manufacturing Chemicals
Rayon fibers are produced via industrial processes that can use or generate reactive process chemicals. [1] Published health effects related to endocrine or reproductive outcomes in industrial cohorts are more consistently associated with exposure to manufacturing-process chemicals rather than with rayon fiber itself as an endocrine-active substance. [4]
Carbon Disulfide as a Process Chemical With Endocrine/Reproductive Findings
Carbon disulfide is a well-studied industrial chemical used in viscose rayon manufacturing. [3] A toxicological profile describes endocrine organ histopathology findings as negative in rodents for specific dosing regimens. [3] Human data summarized in toxicology materials for carbon disulfide include reports of endocrine alterations and menstrual disturbances in workers exposed in viscose rayon-related settings. [4]
Direct Demonstration of Rayon as an EDC
No authoritative assessment was identified showing rayon fiber itself (as the consumer textile material) meets modern EDC criteria in guideline-style endocrine-disruption frameworks. [1] The available endocrine-disruption discussions most prominently implicate endocrine-active effects from exposure to specific industrial chemicals used in production rather than from the rayon fiber material after processing. [4]
Practical Implication for Endocrine Risk Attribution
If endocrine disruption is being considered for “rayon,” endocrine-disruption evidence (when present) is more plausibly attributable to specific exposure contaminants or process chemicals rather than to rayon fiber identity. [4] Endocrine-disruption claims should be restricted to chemicals that have demonstrated endocrine-active hazard evidence under recognized assessment approaches. [1]